FDA Inspection 1055734 — Czech-Gen, A.S.

Czech-Gen, A.S. — FEI 3002806982

The FDA completed an inspection of Czech-Gen, A.S. on May 25, 2018 in Olomouc. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 25, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Olomouc (Czech Republic)